Edison Israel

Medison Israel is the Israeli arm of Medison, a private specialty pharmaceutical company focused on bringing innovative therapies, medical devices, and diagnostics to patients in Israel and other international markets. Rather than operating primarily as a drug discovery biotech, the company acts as a commercialization and market-access partner for biotech and pharmaceutical innovators, providing regulatory, medical affairs, market access, distribution, and patient-support capabilities. Medison is particularly active in oncology, hematology, neurology, and rare diseases, and has built partnerships with companies such as Amgen, Biogen, Vertex, Ipsen, Alnylam, argenx, and Immunocore. The company also operates a broader international commercialization platform spanning multiple regions beyond Israel. Its business model is centered on accelerating access to approved or near-commercial innovative therapies in markets that are often underserved by direct pharma infrastructure.